Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients

Publisher Website
Google Scholar
Abstract
A double isotope method was used in patients with progressive malignancy and in control patients to measure: glucose turnover, conversion rate of carbon skeleton of glycerol into glucose, and the interorgan cycling of glucose carbons (Cori‐cycle plus alanine‐glucose cycle). [U‐14Clglycerol and [6‐3H]glucose were given intravenously as a single dose injection. The time course of the specific radioactivities of [6‐3H] and [U‐14C]glucose was followed in blood. The pool size and the turnover rate of glucose were increased in the cancer group as compared with the control patients. The net recycling of glucose carbons was not increased in the cancer group, despite the increased turnover of glucose. The alterations in the metabolism of glucose did not correlate with the plasma levels of insulin or thyroid hormones (T4, T3, rT3) neither in the entire cancer group nor in those cancer patients who were repeatedly investigated at different intervals of time. The turnover rate of glucose in the cancer patients correlated inversely to their body weight index. The gluconeogenesis rate, given as the fractional conversion rate of the injected radioactive dose of [14C]glycerol, or as mol glucose · kg body weight−1 · day−1, was increased in the cancer group, but still contributed only 3% of the glucose turnover rate in both cancer and control patients. We conclude that an increased gluconeogenesis from glycerol is not significant in terms of energy expenditure in patients with progressive malignancy, as has previously been concluded for the gluconeogenesis from alanine.15 It seems that increased turnover of glucose may contribute to inappropriately high energy expenditure in cancer patients.

This publication has 25 references indexed in Scilit: